Caribou Biosciences, Inc. (CRBU)

NASDAQ: CRBU · Real-Time Price · USD

1.270

-0.020 (-1.55%)

At close: Sep 15, 2026, 4:00 PM EDT

1.290

+0.020 (1.57%)

After-hours: Sep 15, 2026, 5:14 PM EDT

Caribou Biosciences Employees

Caribou Biosciences had 97 employees as of December 31, 2025. The number of employees decreased by 50 or -34.01% compared to the previous year.

Employees

97

Change (1Y)

-50

Growth (1Y)

-34.01%

Revenue / Employee

$103,454

Profits / Employee

-$1,066,010

Market Cap

136.15M

Employees Chart

Employees History

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	97	-50	-34.01%
Dec 31, 2024	147	-11	-6.96%
Dec 31, 2023	158	21	15.33%
Dec 31, 2022	137	-	-

Related Stocks

Company Name	Employees
LENZ Therapeutics	152
Nautilus Biotechnology	127
Inovio Pharmaceuticals	112
Tenaya Therapeutics	70
Connect Biopharma Holdings	64
Milestone Pharmaceuticals	38
Biomea Fusion	37
TuHURA Biosciences	22

Employee Rankings

CRBU News

4 weeks ago - Caribou Biosciences reports Q2 EPS (24c), consensus (31c) - TheFly
4 weeks ago - Caribou Biosciences price target lowered to $5 from $6 at BofA - TheFly
4 weeks ago - Caribou Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
4 weeks ago - Caribou Biosciences Quarterly report: Q2 2026 - Filings
4 weeks ago - Caribou Biosciences Earnings release: Q2 2026 - Filings
2 months ago - Caribou Biosciences Transcript: H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - Transcripts
2 months ago - Caribou Biosciences to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference - GlobeNewsWire
3 months ago - Caribou Biosciences Transcript: AGM 2026 - Transcripts